NATUREX : Financial Communications Agenda 2013

le
0

Avignon, January 16th, 2013 - NATUREX, the global leader in specialty plant-based natural ingredients, discloses its financial communications agenda for 2013 :

Publications regarding FY 2012 (as at 31.12.2012)

Annual sales 11 February 2013
instead of 24 January 2013
Annual results 27 March 2013

The meeting for the presentation of NATUREX 2012 annual results (SFAF meeting) will be held on 28 March 2013 in Paris.

The Shareholders' meeting called to approve the financial statements as at 31 December 2012 will be held on 26 June 2013 in Paris. Publications regarding FY 2013 (as at 31.12.2013)

1st quarter sales 26 April 2013
1st quarter results 29 May 2013
1st half-year sales 25 July 2013
1st half-year results 30 August 2013
3rd quarter sales 5 November 2013
3rd quarter results 29 November 2013
Annual sales 4 February 2014
Annual results 27 March 2014

This schedule is given for information, it is subject to change if the Company deems it necessary.
Publications will be released after the close of market (NYSE Euronext Paris).

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com

Naturex has been listed since October 1996 on NYSE Euronext in Paris, compartment B

Total number of shares comprising the share capital: 7,728,539
ISIN FR0000054694

Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex

Naturex is a global leader in speciality plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, UAE, Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).

Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

Contacts
Thierry Lambert
Chairman and Chief Executive Officer
Tel: +33 (0)4 90 23 96 89
t.lambert@naturex.com
 
 
Thierry Bertrand Lambert
Chief Financial Officer
Tel: +33 (0)4 90 23 96 89
t.blambert@naturex.com
 
 
Carole Alexandre
Investor Relations
Tel: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-30689-cp-naturex-160113.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant